BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11603883)

  • 1. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance with atypical antipsychotics.
    Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
    Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
    Sernyak MJ; Gulanski B; Rosenheck R
    J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy.
    Gupta S; Steinmeyer C; Frank B; Madhusoodanan S; Lockwood K; Lentz B; Keller P
    Am J Ther; 2003; 10(5):348-55. PubMed ID: 12975719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
    Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
    J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
    Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
    J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of prolactin levels by atypical antipsychotics.
    Turrone P; Kapur S; Seeman MV; Flint AJ
    Am J Psychiatry; 2002 Jan; 159(1):133-5. PubMed ID: 11772702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.
    Muench J; Carey M
    J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics and hyperglycaemia.
    Mir S; Taylor D
    Int Clin Psychopharmacol; 2001 Mar; 16(2):63-73. PubMed ID: 11236071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.